— Know what they know.
Not Investment Advice

603707.SS SHH

Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd.
1W: +3.1% 1M: +3.1% 3M: +9.8% YTD: -18.4% 1Y: -28.4% 3Y: -37.5% 5Y: -66.3%
¥8.19 ($1.22)
+0.30 (+3.80%)
 
SHH · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 54 · ¥13.2B mcap · 1.29B float · 0.975% daily turnover

📊 Key Metrics

TTM
¥4B
Revenue
+4.7% YoY
¥483M
Net Income
-31.7% YoY
¥2B
Free Cash Flow
+125.3% YoY
33.1%
Gross Margin
10.5%
Op. Margin
9.9%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE7.1%
ROA4.7%
ROIC8.2%

Valuation

P/E27.4
P/B1.9
EV/EBITDA15.0

Leverage

Debt/Equity0.37
Current Ratio2.15
Interest Cov.10.2x

Quality Scores

Piotroski F3/9
Altman Z3.29
Beneish M-2.81

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms